About Bevacizumab | Risks and Benefits

Drug Index: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

	Post Bevacizumab Side Effect Reporting Your Bevacizumab side effect will help others recognize and deal with Bevacizumab side effects.
	Ask Community Ask patient community about Bevacizumab related health issues.
	Recent Reports View Bevacizumab reports recently posted by other patients.
	FDA Bevacizumab Reports Learn about Bevacizumab adverse events reported to FDA.

Bevacizumab

News Aggregator

Aggregates results from the best known news search sites (Google, Yahoo, and, Microsoft(Live) )... These sites searches alllllllllllllllllllllllllllllllllll the news sites available, efficiently... Fetches news simultaneously by running parallel threads... Sorts the news based on publication date of the news(latest first)...

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"></font></td><td valign="top" class="j"><font style="font-size:85%;font-family:arial, sans-serif;"><br /><div style="padding-top:0.8em;"><img alt="" height="1" width="1"/></div><div class="lh"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG9fQGZzzN6Bhzo4M9eUaoptM

ISSUE: The FDA is warning healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States. The counterfeit version is labeled as ...

The counterfeit version of Avastin does not contain the medicine’s active ingredient, bevacizumab, which may have resulted in patients not receiving needed therapy. Based on information to date, FDA has determined that none of the unapproved ...

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGQ8UXUU1ljLm0wrTxR6_qC0irhwg&url=http://yourlife.usatoday.com/health/story/2012-02-14/Roche-warns-of-counterfeit-Avastin-in-US/53096312/1"><img alt="" border="1" width="80" height="80"/><br /><font size="-2">USA

(RTTNews) - Genentech, a member of the Roche Group (RHHBY.PK: News ), warned that a counterfeit product, labeled as Avastin or bevacizumab, has been distributed in the United States. Genentech said that Chemical analyses of the counterfeit vials tested to ...

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"></font></td><td valign="top" class="j"><font style="font-size:85%;font-family:arial, sans-serif;"><br /><div style="padding-top:0.8em;"><img alt="" height="1" width="1"/></div><div class="lh"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGQdRXSYS-MjMHpjvEDTyNFRf

Colorectal cancer affects the lower digestive tract comprising of the colon and rectum. It lists among the most common cancers in the developed countries. It can spread to neighboring organs or distant sites; spread to distant sites is referred to as ...

This increased risk and incidence of fatal adverse events reported for bevacizumab "are on the same scale" as those described in this meta-analysis looking at pazopanib, sorafenib, and sunitinib, note Dr. Choueiri and colleagues. In both cases, hemorrhage ...

This may even serve as the mechanism by which these tumors fail to respond to bevacizumab treatment. That means that treatments to attack the invasiveness of gliomas by attacking CD97 expression may have special promise as a new treatment strategy."

Colorectal cancer is the third most common cancer and the third leading cause of cancer-related death. Bevacizumab is a humanized monoclonal antibody developed against vascular endothelial growth factor (VEGF) for the treatment of metastatic cancer.

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGZF2JiOOM3WNgnjF_Mrzz3BuBdkg&url=http://www.thirdage.com/news/avastin-extends-survival-rate-for-throat-cancer_01-30-2012"><img alt="" border="1" width="80" height="80"/><br /><font size="-2">ThirdAge</font></a></

Hi. I'm Mark Kris from Memorial Sloan-Kettering Cancer Center in New York and I'm making my first commentary of the new year. Happy New Year. May it bring great hope and happiness to everybody listening and to our patients as well. I thought I ...

Patients with advanced nasopharyngeal carcinoma achieved favorable overall survival when bevacizumab (Avastin) was added to upfront and adjuvant therapy. Point out that no grade 3 or 4 hemorrhagic adverse events were observed with this combination.

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHvZQawTg06SApeCPlqQm-GnlMybA&url=http://www.mdnews.com/news/hd/2012_05/hd_661015"><img alt="" border="1" width="80" height="80"/><br /><font size="-2">MD News (press release)</font></a></font></td><td valign="top

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHt5nsVXMKCSyERlaO81QSCoELl2A&url=http://www.familypracticenews.com/news/more-top-news/single-view/bevacizumab-boosts-treatment-responses-in-early-breast-cancer/521611dd50.html"><img alt="" border="1" width="80" h

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG_wymiHQ1CVYWYB8uc0C8jUWL_Yw&url=http://www.familypracticenews.com/news/more-top-news/single-view/gastric-cancer-subtype-may-affect-bevacizumab-benefit/6593f1e34c.html"><img alt="" border="1" width="80" height="8

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEspk1_9x6PoK6Xz5by-zUWvQ88qw&url=http://www.osnsupersite.com/view.aspx?rid%3D90789"><img alt="" border="1" width="80" height="80"/><br /><font size="-2">OSN SuperSite</font></a></font></td><td valign="top" class=

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"></font></td><td valign="top" class="j"><font style="font-size:85%;font-family:arial, sans-serif;"><br /><div style="padding-top:0.8em;"><img alt="" height="1" width="1"/></div><div class="lh"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH43_dF0Y0O6CPxX5SN_bVUgJ

Bevacizumab is a humanized monoclonal antibody to human vascular endothelial cell growth factor (VEGF) and has been used for many types of cancers such as colorectal cancer, non-small cell lung cancer, breast cancer, and glioblastoma. Bevacizumab might be ...

<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"><tr><td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial, sans-serif;"></font></td><td valign="top" class="j"><font style="font-size:85%;font-family:arial, sans-serif;"><br /><div style="padding-top:0.8em;"><img alt="" height="1" width="1"/></div><div class="lh"><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHYbkjD-BOWXIVZW4zviKlzn9

Yahoo! Answers: Search for

Yahoo! Answers: Search for

Bevacizumab, an antibody against a vascular growth factor A, has shown clinical efficacy in people with HER2 negative metastatic breast cancer. 1948 patients with a median tumor size of 40mm were randomly assigned to recieve eprubicin and cyclophosphamid followed by docetaxel, with or without bevacizumab. Patients with untreated HER2 were eligable if they had large tumors and no risk of bleeding or increased cardiovascular problems.

Despite having her right kidney removed some 2.5 years ago, my mom's renal cell cancer has spread. Her doctor has suggested that if certain tests and scans confirm her suitability, she join a trial comparing two treatment regimens - everolimus plus bevacizumab versus bevacizumab plus interferon alfa. Will the regimens help prolong her life? If so, by how much?

My science fair is about anti-angiogenesis drugs paried with other cancer treatments. It will talk about normal angiogenesis and pathological angiogenesis, in other words the treatment drugs like Bevacizumab and how they normalize vasculature in tumors and prevent metastasis. I am doing this project for a grade 10 science fair. I am supposed to think of a catchy name, and I was thinking of "Killing them with kindness" in reference to normalizing vasculature in tumors before they are destroyed.

My science fair is about anti-angiogenesis drugs paried with other cancer treatments. It will talk about normal angiogenesis and pathological angiogenesis, in other words the treatment drugs like Bevacizumab and how they normalize vasculature in tumors and prevent metastasis. I am doing this project for a grade 10 science fair. I am supposed to think of a catchy name, and I was thinking of "Killing them with kindness" in reference to normalizing vasculature in tumors before they are destroyed.

My science fair is about anti-angiogenesis drugs paried with other cancer treatments. It will talk about normal angiogenesis and pathological angiogenesis, in other words the treatment drugs like Bevacizumab and how they normalize vasculature in tumors and prevent metastasis. I am doing this project for a grade 10 science fair. I am supposed to think of a catchy name, and I was thinking of "Killing them with kindness" in reference to normalizing vasculature in tumors before they are destroyed.

i think it blocks paracrine vegf signaling, but im not sure about autocrine. help is greatly appreciated. thanks!

Last Febuary (2006) I finished chemo for breast cancer I took the following chemos: Brand Generic Ellence epirubicin Cytoxan cyclophosphamide Adrucil 5-Fu, fluorouracil Taxotere docetaxel Xeloda capecitabine Platinol cisplatin Vepecid,VP16 etoposide Avastin bevacizumab How long might it take for my cycles to become regular?

More specifically, is the "-ci-" prounounced "-ky-", "-ki-", "-sy-", "-si-", or something else?

My mother has this problem, and she has just entered into a 'clinical trail to monitor the effect of intravitreal bevacizumab', is anyone also on this trail? If so, have you or the person you know, noticed a difference in the eyesight like it improving or worsening? If you have, how long has this person been on the trail? What ever help and advice you can give me to pass onto my mother would be very much appreciated? Thank you.

Loading

Share Your Bevacizumab Experience

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.We hope you found our information about b>Bevacizumab. About Bevacizumab : Latest News, Updates, Risks and Benefits